Nutritional Supplement

Inositol

  • Stress and Mood Management

    Depression

    People with depression may have lower levels of inositol. Supplementing with this nutrient may correct a deficiency and improve depression symptoms.
    Depression
    ×
     

    Preliminary evidence indicates that people with depression may have lower levels of inositol.1 Supplementation with large amounts of inositol can increase the body’s stores by as much as 70%.2 In a double-blind trial, depressed people who received 12 grams of inositol per day for four weeks had a significant improvement in symptoms compared to those who took placebo.3 In a double-blind follow-up to this trial, the antidepressant effects of inositol were replicated. Half of those who responded to inositol supplementation relapsed rapidly when inositol was discontinued.4

    Anxiety

    Inositol has been used to help people with anxiety who have panic attacks.
    Anxiety
    ×
     

    Inositol has been used to help people with anxiety who have panic attacks. Up to 4 grams three times per day was reported to control such attacks in a double-blind trial.5 Inositol (18 grams per day) has also been shown in a double-blind trial to be effective at relieving the symptoms of obsessive-compulsive disorder.6

  • Brain Health

    Anxiety

    Inositol has been used to help people with anxiety who have panic attacks.
    Anxiety
    ×
     

    Inositol has been used to help people with anxiety who have panic attacks. Up to 4 grams three times per day was reported to control such attacks in a double-blind trial.7 Inositol (18 grams per day) has also been shown in a double-blind trial to be effective at relieving the symptoms of obsessive-compulsive disorder.8

    Bipolar Disorder

    Inositol may be useful for treating depression in people with bipolar disorder.
    Bipolar Disorder
    ×
     

    Inositol is a nutrient found in large amounts in the brain, but its possible role in mood disorders is unclear. Inositol levels may be reduced in certain parts of the brains of depressed and bipolar patients.9 However, lithium reduces normal brain levels of inositol, and this may be one of the ways lithium helps people with bipolar disorder.10,11,12 Although inositol is known to have significant antidepressant properties when administered in large amounts of 12 grams per day,13,14 case reports involving bipolar patients have reported either no benefit,15 some benefit,16 or worsening of symptoms from inositol supplementation.17 Until controlled research clarifies the effects of inositol in people with bipolar illness, it should only be used under the supervision of a qualified healthcare practitioner.

  • Blood Sugar and Diabetes Support

    Type 2 Diabetes

    Inositol has been shown to improve glucose metabolism and insulin sensitivity in women with polycystic ovarian syndrome, and preliminary evidence suggests it may lower HbA1c in people with type 2 diabetes.
    Type 2 Diabetes
    ×
    Disturbances in inositol metabolism are thought to be an underlying factor in insulin resistance and type 2 diabetes.18 Animal studies suggest inositol may reduce glucose absorption in the digestive tract and have insulin-like effects, increasing glucose uptake and utilization by cells.19,20 A pilot trial examined the effects of adding inositol in people with type 2 diabetes with persistently high HbA1c despite medical treatment. A supplement providing two types of inositol (550 mg of myo-inositol and 13.8 mg of D-chiro inositol per day) was added to their treatment. After three months, fasting blood glucose levels and HbA1c had decreased significantly.21 Reviews of clinical research have shown that inositol can improve glucose metabolism and insulin sensitivity in women with polycystic ovarian syndrome (PCOS), a condition marked by hormonal imbalance and increased risk of insulin resistance, type 2 diabetes, and cardiovascular disease.22,23

    Type 1 Diabetes

    Supplementing with inositol may improve diabetic neuropathy.
    Type 1 Diabetes
    ×
    Inositol, particularly in the forms myo-inositol and D-chiro-inositol, has many functions in the body, including assisting in normal cellular responsiveness to insulin.24 A gene alteration that affects inositol metabolism may be associated with risk of type 1 diabetes and its complications, and people with type 1 and type 2 diabetes have been found to lose more myo-inositol in their urine compared to those without diabetes.25,26 In one small pilot trial in seven people with type 1 diabetes, inositol supplementation (500 mg taken twice per day for two weeks) led to improved nerve function; however, two placebo-controlled trials failed to find a benefit.27,28,29
What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

Temp Title
×
Temp Text

References

1. Barkai AI, Dunner DL, Gross HA, et al. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry 1978;13:65-72.

2. Levine J, Rapaport A, Lev L. Inositol treatment raises CSF inositol levels. Brain Res 1993;627:168-70.

3. Levine J, Barak Y, Gonzalves M, et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995;152:792-4.

4. Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an inositol study of depression. Isr J Psychiatry Relat Sci 1995;32:14-21.

5. Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-6.

6. Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 1996;153:1219-21.

7. Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-6.

8. Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 1996;153:1219-21.

9. Shimon H, Agam G, Belmaker RH, et al. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997;154:1148-50.

10. Fauroux CM, Freeman S. Inhibitors of inositol monophosphatase. J Enzyme Inhib 1999;14:97-108 [review].

11. Belmaker RH, Agam G, van Calker D, et al. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmacology 1998;19:220-32 [review].

12. Belmaker RH, Bersudsky Y, Agam G, et al. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med 1996;47:47-56 [review].

13. Levine J, Barak Y, Gonzalves M, et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995;152:792-4.

14. Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an inositol study of depression. Isr J Psychiatry Relat Sci 1995;32:14-21.

15. Souza FG, Mander AJ, Foggo M, et al. The effects of lithium discontinuation and the non-effect of oral inositol upon thyroid hormones and cortisol in patients with bipolar affective disorder. J Affect Disord 1991;22:165-70.

16. Grisaru N, Belmaker RH. Lithium dosage and inositol levels. Br J Psychiatry 1994;164:133-4 [letter].

17. Levine J, Witztum E, Greenberg BD, Barak Y. Inositol-induced mania? Am J Psychiatry 1996;153:839 [letter].

18. Croze M, Soulage C. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95:1811–27.

19. Chukwuma C, Ibrahim M, Islam M. Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study. J Physiol Biochem 2016;72:791–801.

20. Gao Y, Zhang M, Wang T, et al. Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway. Mol Cell Endocrinol 2016;433:26–34.

21. Pintaudi B, Di Vieste G, Bonomo M. The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. Int J Endocrinol 2016;2016:9132052.

22. Unfer V, Nestler J, Kamenov Z, et al. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol 2016;2016:1849162.

23. Genazzani A. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online 2016;33:770–80.

24. Croze M, Soulage C. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95:1811–27.

25. Yang B, Hodgkinson A, Millward B, Demaine A. Polymorphisms of myo-inositol oxygenase gene are associated with Type 1 diabetes mellitus. J Diabetes Complications 2010;24:404–8.

26. Jung T, Hahm J, Kim J, et al. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients. Yonsei Med J 2005;46:532–8.

27. Salway J, Whitehead L, Finnegan J, et al. Effect of myo-inositol on peripheral-nerve function in diabetes. Lancet 1978;2:1282–4.

28. Gregersen G, Bertelsen B, Harbo H, et al. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurol Scand 1983;67:164–72.

29. Gregersen G, Borsting H, Theil P, Servo C. Myoinositol and function of peripheral nerves in human diabetics. Acta Neurol Scand 1978;58:241–8.

30. Levine J, Barak Y, Gonzalves M, et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995;152:792-4.

31. Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an inositol study of depression. Isr J Psychiatry Relat Sci 1995;32:14-21.

32. Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-6.

33. Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 1996;153:1219-21.

34. Colodny L, Hoffman RL. Inositol—Clinical applications for exogenous use. Altern Med Rev 1998;3:432-47.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.